位置:首页 > 蛋白库 > AF9_MOUSE
AF9_MOUSE
ID   AF9_MOUSE               Reviewed;         569 AA.
AC   A2AM29; Q8VDR6; Q99MK4;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 1.
DT   03-AUG-2022, entry version 108.
DE   RecName: Full=Protein AF-9;
DE   AltName: Full=Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein homolog;
GN   Name=Mllt3; Synonyms=Af9;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-569, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INTERACTION WITH CBX8.
RC   STRAIN=Swiss Webster / NIH;
RX   PubMed=11439343; DOI=10.1038/sj.onc.1204478;
RA   Hemenway C.S., de Erkenez A.C., Gould G.C.D.;
RT   "The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in
RT   t(9;11)(p22;q23) acute leukemias.";
RL   Oncogene 20:3798-3805(2001).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Chromatin reader component of the super elongation complex
CC       (SEC), a complex required to increase the catalytic rate of RNA
CC       polymerase II transcription by suppressing transient pausing by the
CC       polymerase at multiple sites along the DNA. Specifically recognizes and
CC       binds acylated histone H3, with a preference for histone H3 that is
CC       crotonylated. Crotonylation marks active promoters and enhancers and
CC       confers resistance to transcriptional repressors. Recognizes and binds
CC       histone H3 crotonylated at 'Lys-9' (H3K9cr), and with slightly lower
CC       affinity histone H3 crotonylated at 'Lys-18' (H3K18cr). Also recognizes
CC       and binds histone H3 acetylated and butyrylated at 'Lys-9' (H3K9ac and
CC       H3K9bu, respectively), but with lower affinity than crotonylated
CC       histone H3. In the SEC complex, MLLT3 is required to recruit the
CC       complex to crotonylated histones. Recruitment of the SEC complex to
CC       crotonylated histones promotes recruitment of DOT1L on active chromatin
CC       to deposit histone H3 'Lys-79' methylation (H3K79me). Plays a key role
CC       in hematopoietic stem cell (HSC) maintenance by preserving, rather than
CC       confering, HSC stemness. Acts by binding to the transcription start
CC       site of active genes in HSCs and sustaining level of H3K79me2, probably
CC       by recruiting DOT1L. {ECO:0000250|UniProtKB:P42568}.
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb
CC       complex and ELL (ELL, ELL2 or ELL3) (By similarity). Interacts with
CC       BCOR (By similarity). Interacts with CBX8 (PubMed:11439343). Interacts
CC       with ALKBH4 (By similarity). {ECO:0000250|UniProtKB:P42568,
CC       ECO:0000269|PubMed:11439343}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00376,
CC       ECO:0000269|PubMed:11439343}. Chromosome
CC       {ECO:0000250|UniProtKB:P42568}. Note=Colocalizes with acylated histone
CC       H3. H3 Colocalizes with histone H3 crotonylated at 'Lys-18' (H3K18cr).
CC       {ECO:0000250|UniProtKB:P42568}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Strong expression in the
CC       spleen. {ECO:0000269|PubMed:11439343}.
CC   -!- DOMAIN: The YEATS domain specifically recognizes and binds acylated
CC       histones, with a marked preference for histones that are crotonylated.
CC       Also binds histone H3 acetylated at 'Lys-9' (H3K9ac), but with lower
CC       affinity. Binds crotonylated lysine through a non-canonical pi-pi-pi
CC       stacking mechanism. The YEATS domain also binds DNA.
CC       {ECO:0000250|UniProtKB:P42568}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL806533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL831756; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL929524; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021420; AAH21420.1; -; mRNA.
DR   EMBL; AF333960; AAK28536.1; -; mRNA.
DR   CCDS; CCDS38796.1; -.
DR   RefSeq; NP_081602.3; NM_027326.3.
DR   AlphaFoldDB; A2AM29; -.
DR   BMRB; A2AM29; -.
DR   SMR; A2AM29; -.
DR   BioGRID; 213873; 9.
DR   DIP; DIP-60099N; -.
DR   IntAct; A2AM29; 4.
DR   STRING; 10090.ENSMUSP00000077232; -.
DR   iPTMnet; A2AM29; -.
DR   PhosphoSitePlus; A2AM29; -.
DR   SwissPalm; A2AM29; -.
DR   EPD; A2AM29; -.
DR   jPOST; A2AM29; -.
DR   MaxQB; A2AM29; -.
DR   PaxDb; A2AM29; -.
DR   PeptideAtlas; A2AM29; -.
DR   PRIDE; A2AM29; -.
DR   ProteomicsDB; 285560; -.
DR   Antibodypedia; 1068; 294 antibodies from 29 providers.
DR   DNASU; 70122; -.
DR   Ensembl; ENSMUST00000078090; ENSMUSP00000077232; ENSMUSG00000028496.
DR   GeneID; 70122; -.
DR   KEGG; mmu:70122; -.
DR   UCSC; uc008tmp.1; mouse.
DR   CTD; 4300; -.
DR   MGI; MGI:1917372; Mllt3.
DR   VEuPathDB; HostDB:ENSMUSG00000028496; -.
DR   eggNOG; KOG3149; Eukaryota.
DR   GeneTree; ENSGT00940000155903; -.
DR   HOGENOM; CLU_036086_0_0_1; -.
DR   InParanoid; A2AM29; -.
DR   OMA; MSKEPKA; -.
DR   OrthoDB; 727038at2759; -.
DR   PhylomeDB; A2AM29; -.
DR   TreeFam; TF314586; -.
DR   Reactome; R-MMU-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-MMU-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-MMU-75955; RNA Polymerase II Transcription Elongation.
DR   BioGRID-ORCS; 70122; 11 hits in 73 CRISPR screens.
DR   ChiTaRS; Mllt3; mouse.
DR   PRO; PR:A2AM29; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; A2AM29; protein.
DR   Bgee; ENSMUSG00000028496; Expressed in embryonic post-anal tail and 277 other tissues.
DR   ExpressionAtlas; A2AM29; baseline and differential.
DR   Genevisible; A2AM29; MM.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0032783; C:super elongation complex; IBA:GO_Central.
DR   GO; GO:0008023; C:transcription elongation factor complex; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB.
DR   GO; GO:0140030; F:modification-dependent protein binding; ISS:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IMP:MGI.
DR   GO; GO:0006338; P:chromatin remodeling; IBA:GO_Central.
DR   GO; GO:0010467; P:gene expression; IDA:MGI.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0016573; P:histone acetylation; IBA:GO_Central.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; ISO:MGI.
DR   GO; GO:1902275; P:regulation of chromatin organization; ISS:UniProtKB.
DR   GO; GO:2000035; P:regulation of stem cell division; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0007379; P:segment specification; IMP:MGI.
DR   Gene3D; 2.60.40.1970; -; 1.
DR   InterPro; IPR040930; AF-9_AHD.
DR   InterPro; IPR038704; YEAST_sf.
DR   InterPro; IPR005033; YEATS.
DR   PANTHER; PTHR23195; PTHR23195; 1.
DR   Pfam; PF17793; AHD; 1.
DR   Pfam; PF03366; YEATS; 1.
DR   PROSITE; PS51037; YEATS; 1.
PE   1: Evidence at protein level;
KW   Activator; Chromosome; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..569
FT                   /note="Protein AF-9"
FT                   /id="PRO_0000305124"
FT   DOMAIN          1..138
FT                   /note="YEATS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00376"
FT   REGION          137..476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           296..301
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        143..195
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        196..262
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        266..280
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        283..305
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        324..355
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        374..404
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        415..429
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        442..462
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         289
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42568"
FT   MOD_RES         295
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42568"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         420
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42568"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42568"
FT   CROSSLNK        340
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P42568"
FT   CONFLICT        157
FT                   /note="S -> G (in Ref. 3; AAK28536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        164
FT                   /note="S -> G (in Ref. 3; AAK28536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        172
FT                   /note="S -> N (in Ref. 3; AAK28536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176
FT                   /note="S -> G (in Ref. 3; AAK28536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        179..190
FT                   /note="Missing (in Ref. 2; AAH21420)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        352
FT                   /note="M -> T (in Ref. 2; AAH21420)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   569 AA;  63375 MW;  120A0604B13675EC CRC64;
     MASSCAVQVK LELGHRAQVR KKPTVEGFTH DWMVFVRGPE HSNIQHFVEK VVFHLHESFP
     RPKRVCKDPP YKVEESGYAG FILPIEVYFK NKEEPKKVRF DYDLFLHLEG HPPVNHLRCE
     KLTFNNPTED FRRKLLKAGG DPNRSIHTSS SSSSSSSSSS SSSSSSSSSS SSSSSSSSSS
     SSSSSSSSSS TSFSKPHKLM KEHKEKPSKD SREHKSAFKE PSRDHNKSSK DSSKKPKENK
     PLKEEKIVPK MAFKEPKPMS KEPKADSNLL TVTSGQQDKK APSKRPPASD SEELSAKKRK
     KSSSEALFKS FSSAPPLILT CSADKKQIKD KSHVKMGKVK IESETSEKKK SMLPPFDDIV
     DPNDSDVEEN MSSKSDSEQP SPASSSSSSS SSFTPSQTRQ QGPLRSIMKD LHSDDNEEES
     DEAEDNDNDS EMERPVNRGG SRSRRVSLSD GSDSESSSAS SPLHHEPPPP LLKTNNNQIL
     EVKSPIKQSK SDKQIKNGEC DKAYLDELVE LHRRLMTLRE RHILQQIVNL IEETGHFHIT
     NTTFDFDLCS LDKTTVRKLQ SYLETSGTS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024